DeepMed Research

Royal Marsden NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.royalmarsden.nhs.uk

Clinical Trials

A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)

Phase 2

Withdrawn

Conditions: Advanced Melanoma

Interventions: Drug: Pembrolizumab

First Posted Date: 2016-01-26

Last Posted Date: 2017-08-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Registration Number: NCT02663258

Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy

Conditions: Toxicity
Malignancy
Cancer

First Posted Date: 2016-01-07

Last Posted Date: 2018-01-30

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 120

Registration Number: NCT02649491

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

GI Consequences Economic Evaluation

Completed

Conditions: Cancer

Interventions: Other: GIANT Completed patient

First Posted Date: 2016-01-06

Last Posted Date: 2018-01-30

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 21

Registration Number: NCT02647450

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

The Effect of an Aromatherapy Intervention on Sleep in the ICU

Not Applicable

Conditions: Sleep Deprivation

Interventions: Other: Aroma Therapy Massage and Inhalation Patch

First Posted Date: 2015-12-08

Last Posted Date: 2015-12-08

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 50

Registration Number: NCT02623686

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

Comparing Immobilisation Shells in Cranial Radiotherapy

Not Applicable

Completed

Conditions: Bone Metastases
Brain Tumor - Metastatic
Brain Tumor Adult
Brain Tumor, Primary
Brain Metastases

First Posted Date: 2015-11-06

Last Posted Date: 2020-05-05

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 41

Registration Number: NCT02599142

Locations: 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

Pembrolizumab and Palliative Radiotherapy in Lung

Phase 1

Completed

Conditions: Thoracic Tumours

Interventions: Drug: Pembrolizumab
Radiation: Radiotherapy

First Posted Date: 2015-10-27

Last Posted Date: 2024-05-14

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 24

Registration Number: NCT02587455

Locations: 🇬🇧
NIHR Biomedical Research Centre at RM and ICR (https://www.cancerbrc.org/), Sutton, United Kingdom

Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine

Not Applicable

Completed

Conditions: Metastatic Breast Cancer

Interventions: Device: CanADVICE+® (smart phone app)

First Posted Date: 2015-10-20

Last Posted Date: 2018-11-02

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 16

Registration Number: NCT02580396

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Trial of Pembrolizumab and Radiotherapy in Melanoma

Phase 2

Terminated

Conditions: Melanoma

Interventions: Drug: Pembrolizumab
Radiation: Radiotherapy

First Posted Date: 2015-09-29

Last Posted Date: 2020-04-09

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 234

Registration Number: NCT02562625

Locations: 🇬🇧
Royal Marsden, London, United Kingdom

Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer

Phase 1

Conditions: Invasive Bladder Cancer

Interventions: Drug: Pembrolizumab
Radiation: Radiotherapy

First Posted Date: 2015-09-25

Last Posted Date: 2021-04-19

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 34

Registration Number: NCT02560636

Locations: 🇬🇧
NIHR Biomedical Research Centre at RM and ICR (https://www.cancerbrc.org/), Sutton, United Kingdom

Mri IN STaging REctal Polyp Planes

Not Applicable

Conditions: Rectal Cancer
Colonic Polyps
Rectal Neoplasms

Interventions: Other: Novel Pelvic MRI scan assessment

First Posted Date: 2015-08-26

Last Posted Date: 2018-09-14

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 55

Registration Number: NCT02532803

Locations: 🇬🇧
Croydon University Hospital, Thornton Heath, Croydon, United Kingdom
🇬🇧
West Middlesex Hospital, Isleworth, London, United Kingdom
🇬🇧
Queen Alexandra Hospital, Portsmouth, Hampshire, United Kingdom

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy